Loading data
BGMSNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0 USD | 43 k USD | — | — | — |
| Research and development expense | 848 k USD | 6.66 m USD | 19.16 m USD | 20.27 m USD | 14.93 m USD |
| Selling, general and administrative expense | — | 5.39 m USD | 6.72 m USD | 7.38 m USD | 7.46 m USD |
| Operating profit | -8.43 m USD | -12 m USD | -25.45 m USD | -27.66 m USD | -22.39 m USD |
| Profit before tax | -2.99 m USD | -11.99 m USD | -25.55 m USD | -25.92 m USD | -22.19 m USD |
| Income tax expense | 7 k USD | -782 k USD | -3 m USD | -4.72 m USD | -3.73 m USD |
| Net income (reported basis) | -3 m USD | -11.21 m USD | 22.56 m USD | 21.2 m USD | -18.5 m USD |
| Net income attributable to common shareholders | -14.09 m USD | -11.21 m USD | -22.76 m USD | — | — |
| Basic earnings per share | -6.45 USD/share | -502.46 USD/share | -6,419.18 USD/share | -1.9 USD/share | -2.09 USD/share |
| Diluted earnings per share | -6.45 USD/share | -502.46 USD/share | -6,419.18 USD/share | -27.24 USD/share | -2.09 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.